Corvus anticipates PTCL futility analysis in Q1 2027 while guiding cash runway into Q2 2028

Corvus Q3 2026 earnings call: track soquelitinib milestones, 2027 data catalysts, cash runway to Q2 2028, and trial timing shifts.

CryptoAlerta — análise de criptomoedas e mercado em tempo real